Industry News
Pharmaceutical Industry News
Elizabeth Holmes Trial Exposes Investors’ Lack of Due Diligence
Start-up investors have often suspended skepticism while chasing a hot deal. The trial of Ms. Holmes, the founder of Theranos, has put that behavior under the spotlight.
U.K. Authorizes Merck’s Antiviral Pill for Covid-19
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a step toward taming the pandemic.
Surprise COVID-19 antibody sales of $804M help Regeneron trounce expectations in third quarter
Surprise COVID-19 antibody sales of $804M help Regeneron trounce expectations in third quarter kdunleavy Thu, 11/04/2021 - 11:06
Merck and Ridgeback’s COVID-19 oral antiviral molnupiravir joins the pandemic response with U.K. nod
Merck and Ridgeback's COVID-19 oral antiviral molnupiravir joins the pandemic response with U.K. nod esagonowsky Thu, 11/04/2021 - 10:58
Novartis exits 20-year Roche stake, creating a $20.7B question about CEO Vas Narasimhan’s next M&A move
Novartis exits 20-year Roche stake, creating a $20.7B question about CEO Vas Narasimhan's next M&A move aliu Thu, 11/04/2021 - 10:34
Shipping delays, supply chain expansions ding Moderna’s COVID-19 vaccine business
Shipping delays, supply chain expansions ding Moderna's COVID-19 vaccine business esagonowsky Thu, 11/04/2021 - 09:42
Catalent telegraphs more growth in Indiana with $1.2M land deal: report
Catalent telegraphs more growth in Indiana with $1.2M land deal: report jkeenan Thu, 11/04/2021 - 09:19
Inceptor Bio snaps up Arranta Bio manufacturing site as it preps to move preclinical cell therapies forward
Inceptor Bio snaps up Arranta Bio manufacturing site as it preps to move preclinical cell therapies forward jkeenan Thu, 11/04/2021 - 08:11
For pharma marketers, mobile devices reign supreme. But for how long?
For pharma marketers, mobile devices reign supreme. But for how long? sharon.coey Thu, 11/04/2021 - 06:58
ASH: Chasing AbbVie and J&J’s Imbruvica, BeiGene’s Brukinsa fleshes out competitive leukemia data again
ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again aliu Thu, 11/04/2021 - 06:31
Who Can Make mRNA Vaccines?
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether there were companies that could do it.
Yet another Acceleron investor challenges Merck’s $11.5B acquisition offer: Bloomberg
Yet another Acceleron investor challenges Merck’s $11.5B acquisition offer: Bloomberg aliu Wed, 11/03/2021 - 11:51
After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says
After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says esagonowsky Wed, 11/03/2021 - 11:30
Incyte investigates all batches of new eczema cream Opzelura after reports of ‘texture problem’
Incyte investigates all batches of new eczema cream Opzelura after reports of 'texture problem' aliu Wed, 11/03/2021 - 10:53
Merck will support Saudi Arabia effort to build biologics manufacturing operations
Merck will support Saudi Arabia effort to build biologics manufacturing operations jkeenan Wed, 11/03/2021 - 10:25
Amgen’s Lumakras off to a strong start toward analyst’s blockbuster predictions pegged to combo potential
Amgen's Lumakras off to a strong start toward analyst's blockbuster predictions pegged to combo potential kdunleavy Wed, 11/03/2021 - 10:16
Democrats Reach Deal to Control Drug Prices in Bill
The provision would, for the first time, allow the government to negotiate prices for some medicines covered by Medicare.
By unanimous vote, CDC advisory committee endorses Pfizer COVID-19 vaccine for kids 5-11
By unanimous vote, CDC advisory committee endorses Pfizer COVID-19 vaccine for kids 5-11 kdunleavy Tue, 11/02/2021 - 18:16
Almirall illuminates the emotional side of psoriasis in new awareness campaign
Almirall illuminates the emotional side of psoriasis in new awareness campaign nmissakian Tue, 11/02/2021 - 17:35
Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease
Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease sharon.coey Tue, 11/02/2021 - 12:57